Browse > Article

Long-Term Survival of Patients with Lung Cancer Treated by Traditional Korean Medicine Combined with Western Treatment: Report of Two Cases  

Kang, Ji-young (Dept. of Internal Medicine, College of Korean Medicine, Dae-Jeon University)
Kim, Jun-young (Dept. of Internal Medicine, College of Korean Medicine, Dae-Jeon University)
Son, Chang-gue (Dept. of Internal Medicine, College of Korean Medicine, Dae-Jeon University)
Cho, Jung-hyo (Dept. of Internal Medicine, College of Korean Medicine, Dae-Jeon University)
Publication Information
The Journal of Internal Korean Medicine / v.36, no.1, 2015 , pp. 58-68 More about this Journal
Abstract
Objectives : To evaluate the long-term survival effects of traditional Korean medicine (TKM) on refractory metastatic lung cancer and small cell lung cancer (SCLC), which have historically poor survival rates. Methods : A retrospective study was conducted using the medical records of two patients in Daejeon University hospital. The first patient, with SCLC, was treated from January 2000 to December 2009 and the other, with metastatic pulmonary cancer from primary hepatocellular carcinoma (HCC), was treated from September 2004 to February 2014. The patients were treated with herbal medicines at one-month intervals. During hospitalization, acupuncture and indirect moxibustion were performed concurrent with the administration of Western therapy. Treatment efficacy was assessed monthly using chest radiography, chest computed tomography, and laboratory examination data, and by measuring patient performance status. Results : Both patients exhibited a stable disease course for more than 9 years after the initial diagnosis of intractable lung cancer, suggesting that their disease status was controlled by TKM. Conclusions : We suggest that a combination of TKM with conventional Western therapy for refractory lung cancer patients is effective in controlling various symptoms related to lung cancer and improving quality of life, and may potentially prolong overall survival.
Keywords
lung cancer; long-term survival; traditional Korean medicine (TKM);
Citations & Related Records
연도 인용수 순위
  • Reference
1 Sheehan J, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors. J Neurosurg (Suppl) 2005;102:247-54.   DOI
2 Cohen MH, Matthew MJ. Small cell bronchogenic carcinoma: A distinct clinicopathologic entity. Semin Oncol 1978;5(3):234-8.
3 Katyal S, Oliver J Ш, Peterson MS, Ferris JV, Carr BS, Baron RL. Extrahepatic metastases of hepatocellular carcinoma. Radiology 2000; 216:698-703.   DOI   ScienceOn
4 Choi JH, Yoo HS, Son CG, Cho CK. Regression of small cell lung carcinoma by herbal medicine: A case with an 8-year follow-up. J Korean Oriental Oncol 2005;10(1):87-9.
5 Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 1982;5:649-55.   DOI
6 Uka K, Aikata H, Takaki S, Shirakawa H, Jeong SC, Yamashina K, et al. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol 2007;13:414-20.   DOI
7 Jeong TY, Park BK, Lee YW, Cho CK, Yoo HS. Prospective analysis on survival outcomes of nonsmall cell lung cancer stages over IIIb treated with HangAm-Dan. Chin J Lung Cancer 2010;13(11):1009-15.
8 Park BK, Yoo HS, Lee YW, Han SW, Cho JH, Son CG, et al. Retrospective cohort analysis for lung cancer patients treated with Wheel Balance Therapy (WBT). J Korean Orient Int Med 2007;28(3):531-43.
9 Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-47.   DOI
10 Lee DE, Lee SY, Kim JS, Cho CK, Yoo HS , Choi SJ. Antitumor effect of HangAm-Dan (HAD) and its ingredients on Calu6 and MCF-7 human cancer cell lines. J Korean Oriental Med 2009;30(5):50-60.
11 Yoo HS, Kim SH, Lee YH, Cho CK, Lee KH. Two cases of endometrial cancer treated with palliative herbal medication Hangam-dan (HAD). J Korean Oriental Med 2007;28(4):176-80.
12 Oh YS, Oh MS, Son CG, Cho CK, Song TY. The effects of PSM on immune response. J Korean Oriental Med 2001;22(1):46-52.
13 Shin JW, Son JY, OH SM, Han SH, Wang JH, Cho JH, et al. An herbal formula, CGX, exerts hepatotherapeutic effects on dimethylnitrosamine-induced chronic liver injury model in rats. World J Gastroenterol 2006;12(38):6142-8.   DOI
14 Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.   DOI
15 Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A, et al. Changing epidemiology of small cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiology, and end results database. J Clin Oncol 2006;24:4539-44.   DOI
16 Jackman DM, Johnson BE. Small cell lung cancer. Lancet 2005;366:1385-96.   DOI
17 Patel AM, Dunn WF, Trastek VF. Staging systems of lung cancer. Mayo Clin Proc 1993;68 :475-82.   DOI
18 Honeybourne D. Lung metastases from a primary hepatocellular carcinoma. Thorax. 1980;35:316-37.   DOI
19 Kato Y, Ferguson TB, Bennett DE, Burford TH. Oat cell carcinoma of the lung: a review of 138 cases. Cancer 1969;23:517-24.   DOI